chr20-58652112-C-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001001433.3(STX16):c.106C>A(p.Pro36Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000883 in 1,614,172 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P36S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001001433.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STX16 | NM_001001433.3 | c.106C>A | p.Pro36Thr | missense_variant | 1/9 | ENST00000371141.8 | |
STX16-NPEPL1 | NR_037945.1 | n.860C>A | non_coding_transcript_exon_variant | 1/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STX16 | ENST00000371141.8 | c.106C>A | p.Pro36Thr | missense_variant | 1/9 | 2 | NM_001001433.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000532 AC: 81AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000562 AC: 140AN: 249004Hom.: 0 AF XY: 0.000682 AC XY: 92AN XY: 134824
GnomAD4 exome AF: 0.000920 AC: 1345AN: 1461820Hom.: 1 Cov.: 31 AF XY: 0.000946 AC XY: 688AN XY: 727216
GnomAD4 genome AF: 0.000532 AC: 81AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 19, 2022 | - - |
Pseudohypoparathyroidism type 1B Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at